Cephalon To Pay $425M To End Federal Investigation
Drugmaker Cephalon Inc. has agreed to pay $425 million to settle an investigation into the company's sales and marketing practices by the Philadelphia U.S. Attorney's office and the U.S. Department of...To view the full article, register now.
Already a subscriber? Click here to view full article